The potential of AI in advancing genomics: an interview with Avantika Lal

Written by Avantika Lal (Insitro)
Drug discovery & development Medical imaging and biomedical diagnostics Multi-omics research Opinion

In this interview we speak with Avantika Lal from the pharmaceutical start-up Insitro (CA, USA) about how AI can be applied to genomic data from patients in order to help us better understand the molecular processes underlying complex human diseases. Lal also explains how she identifies drug targets from single-cell genomic data by utilizing deep learning and how she would like to see this area of AI advance over the next few years. What sparked your interest in AI in genomics and how has the field progressed since? Human cells have a complex, multifaceted set of mechanisms to control the...

Get Free Access in Just 30 Seconds

Register below to unlock all our content - it's completely free.

You will also receive:

  • Exclusive interviews with thought leaders and in-depth analysis
  • Discounted tickets to top industry events like GIANT Health and the London Biotechnology Show